Discover how new IBD therapies, combo drugs, and microbiome research aim to predict response, prevent Crohn’s complications, and expand trial options.
Russell Cohen, MD
Advertisement
Articles by Russell Cohen, MD
Discover how intestinal ultrasound and biomarkers help spot hidden IBD inflammation, guiding faster treat-to-target decisions beyond endoscopy.
Explore emerging IBD treatments—TL1A blockers, microRNA, stem cells—and new small-bowel imaging, plus team-based care improving access.
UChicago GI faculty bring expert endoscopy and IBD care closer to you, with seamless hospital follow-up and cutting-edge clinical trials.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
AXIOMATIC-TKR: Milvexian Decouples Thrombosis, Hemostasis in DVT
2
SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes
3
REMAIN-1: Improved GLP-1-Induced Weight Loss Retention With Revita DMR System
4
FDA Grants Obinutuzumab Priority Review as Primary Membranous Nephropathy’s Potential First Therapy
5